About Algentech
Algentech is a company based in Evry-courcouronnes (France) founded in 2009. Algentech has raised $253.19 thousand across 1 funding round from investors including Intuitis. Algentech offers products and services including Bioproduction Platform, Melanin, Antimicrobials, and Nucleic Acids. Algentech operates in a competitive market with competitors including GSK, Benson Hill, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
- Headquarter Evry-courcouronnes, France
-
Sectors
HealthcareAgriculture
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$253.19 K (USD)
in 1 rounds
-
Latest Funding Round
$253.19 K (USD), Seed
Jul 01, 2012
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Algentech
Algentech offers a comprehensive portfolio of products and services, including Bioproduction Platform, Melanin, Antimicrobials, and Nucleic Acids.
Platform for customized plant-based biomolecule production
Pigment for industrial applications via sustainable methods
Agents to combat microbes in eco-friendly ways
DNA and RNA produced for pharmaceutical uses
Funding Insights of Algentech
Algentech has successfully raised a total of $253.19K through 1 strategic funding round. The most recent funding activity was a Seed round of $253.19 thousand completed in July 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Algentech
Algentech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Intuitis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Algentech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Algentech
Investment portfolio details for Algentech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Algentech
Detailed financials for Algentech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Algentech Comparisons
Peer comparison for Algentech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Algentech
Algentech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Benson Hill, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Provider of plant-based food ingredients
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
Detailed competitors of Algentech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Algentech
Complete news archive for Algentech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Algentech
Algentech was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Algentech is headquartered in Evry-courcouronnes, France. It is registered at Evry-courcouronnes, Essonne, France.
Algentech is a funded company, having raised a total of $253.19K across 1 funding round to date.
Algentech was founded in 2009 and is based in Evry Courcouronnes, France, within the biotechnology sector focused on agriculture. Proprietary technologies for targeting genes in plant nuclei, transforming chloroplasts, and transporting genetic information into mitochondria are provided. Efforts are directed toward developing amylose-rich wheat lines, tools for transient genetic expression in chloroplasts to avoid nuclear insertions, and cytoplasmic male sterility lines for plant breeding applications.
Algentech's top competitors include Benson Hill, Sutro Biopharma and Cibus.
Algentech offers Bioproduction Platform, Melanin, Antimicrobials, and Nucleic Acids.
Algentech has 1 investor. Key investors include Intuitis.